Age determines the magnitudes of angiotensin II-induced contractions, mRNA, and protein expression of angiotensin type 1 receptors in rat carotid arteries

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69 A, Issue 5, 2014, Pages 519-526

  Vamos, Zoltan ^a,b   Cseplo, Peter ^a,b   Ivic, Ivan ^a   Matics, Robert ^a   Hamar, Janos ^a   Koller, Akos ^a,b,c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Aging; Angiotensin II induced arterial responses; AT1R mRNA expression; AT1R protein expression; Senescence.

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; MESSENGER RNA; VASOCONSTRICTOR AGENT;

AGING; ANGIOTENSIN II-INDUCED ARTERIAL RESPONSES; ANIMAL; ARTICLE; AT1R MRNA EXPRESSION; AT1R PROTEIN EXPRESSION; CAROTID ARTERY; DRUG EFFECT; GENETICS; MALE; METABOLISM; MYOGRAPHY; PHYSIOLOGY; RAT; SENESCENCE.; VASOCONSTRICTION;

AGING; ANGIOTENSIN II-INDUCED ARTERIAL RESPONSES; AT1R MRNA EXPRESSION; AT1R PROTEIN EXPRESSION; SENESCENCE.;

AGING; ANGIOTENSIN II; ANIMALS; CAROTID ARTERIES; MALE; MYOGRAPHY; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84899077245     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt128     Document Type: Article

References (46)

1. Ungvari Z, Bailey-Downs L, Gautam T, et al. Age-Associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta. J Gerontol A Biol Sci Med Sci. 2011;66:866-875
2. Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: Recent advances. J Gerontol A Biol Sci Med Sci. 2012;67:599-610
3. Valcarcel-Ares MN, Gautam T, Warrington JP, et al. Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: Implications for microvascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:821-829
4. Ungvari Z, Tucsek Z, Sosnowska D, et al. Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells. J Gerontol A Biol Sci Med Sci. 2013;68:877-891
5. Wang M, Khazan B, Lakatta EG. Central arterial aging and angiotensin II signaling. Curr Hypertens Rev. 2010;6:266-281
6. Csiszar A, Wang M, Lakatta EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: Role of NF-kappaB. J Appl Physiol. 2008;105:1333-1341
7. Csiszar A, Sosnowska D, Wang M, Lakatta EG, Sonntag WE, Ungvari Z. Age-Associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: Reversal by resveratrol treatment. J Gerontol A Biol Sci Med Sci. 2012;67:811-820
8. Baylis C. Sexual dimorphism: The aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity. J Gerontol A Biol Sci Med Sci. 2012;67:1365-1372
9. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: A novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:313-329
10. Wang M, Takagi G, Asai K, et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension. 2003;41:1308-1316
11. Diz DI. Lewis K. Dahl memorial lecture: The renin-Angiotensin system and aging. Hypertension. 2008;52:37-43
12. Marín J, Rodríguez-Martínez MA. Age-related changes in vascular responses. Exp Gerontol. 1999;34:503-512
13. Konishi C, Naito Y, Saito Y, Ohara N, Ono H. Age-related differences and roles of endothelial nitric oxide and prostanoids in angiotensin II responses of isolated, perfused mesenteric arteries and veins of rats. Eur J Pharmacol. 1997;320:175-181
14. Tschudi MR, Lüscher TF. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins. Circulation. 1995;91:2415-2422
15. Bagi Z, Erdei N, Koller A. High intraluminal pressure via H2O2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors. Am J Physiol Heart Circ Physiol. 2008;295:H835-H841
16. Leite R, Esteväo R, Resende AC, Salgado MC. Role of endothelium in angiotensin II formation by the rat aorta and mesenteric arterial bed. Braz J Med Biol Res. 1997;30:649-656
17. Hunyady L, Catt KJ, Clark AJ, Gáborik Z. Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul Pept. 2000;91:29-44
18. Li Y, Mingqi Z, Wei W, et al. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst. 2010;11(4):214-221
19. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care. 2008;31(suppl 2):S170-S180
20. Rothwell PM. The Interrelation between carotid, femoral and coronary artery disease. Eur Heart J. 2001;22(1):11-14
21. Veresh Z, Debreczeni B, Hamar J, Kaminski PM, Wolin MS, Koller A. Asymmetric dimethylarginine reduces nitric oxide donor-mediated dilation of arterioles by activating the vascular renin-Angiotensin system and reactive oxygen species. J Vasc Res. 2012;49:363-372
22. Allen AM, Zhuo J, Mendelsohn FA. Localization of angiotensin AT1 and AT2 receptors. J Am Soc Nephrol. 1999;10(suppl 11):S23-S29
23. Chiba S, Tsukada M. Angiotensin II-induced tachyphylactic constrictions in isolated and perfused canine mesenteric arteries. Tohoku J Exp Med. 1986;150:417-426
24. Zhang LN, Meng QJ, Zhang LF, Ma J. [A study on gene expression of angiotensin receptors in arteries from tail-suspended rats]. Space Med Med Eng (Beijing). 2002;15:343-346
25. Sechi LA, Griffin CA, Giacchetti G, et al. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension. 1996;28:403-408
26. Bartha E, Solti I, Kereskai L, et al. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats. Cardiovasc Res. 2009;83:501-510
27. Nguyen Dinh Cat A, Touyz RM. A new look at the renin-Angiotensin system-focusing on the vascular system. Peptides. 2011;32: 2141-2150
28. Wakabayashi I, Sakamoto K, Hatake K, Yoshimoto S, Kurahashi M. Effect of age on contractile response to angiotensin II in rat aorta. Life Sci. 1990;47:771-779
29. Quinn R. Comparing rat's to human's age: How old is my rat in people years? Nutrition. 2005;21:775-777
30. Franklin SS, Gustin W IV, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315
31. Kostis JB. Treatment of hypertension in older patients: An updated look at the role of calcium antagonists. Am J Geriatr Cardiol. 2003;12:319-327
32. Cassis P, Conti S, Remuzzi G, Benigni A. Angiotensin receptors as determinants of life span. Pflugers Arch. 2010;459:325-332
33. McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol. 2007;34:665-671
34. Anishchenko TG, Semyachkina-Glushkovskaya OV, Berdnikova VA, Sindyakova TA. Effect of age and sex on blood pressure, development of renal hypertension, and concentration of nitric oxide in the blood of albino rats. Bull Exp Biol Med. 2010;149:1-3
35. Juul B, Aalkjaer C, Mulvany MJ. Responses of femoral resistance vessels to angiotensin in vitro. Eur J Pharmacol. 1987;135:61-68
36. Machii H, Saitoh S, Kaneshiro T, Takeishi Y. Aging impairs myocardium- induced dilation in coronary arterioles: Role of hydrogen peroxide and angiotensin. Mech Ageing Dev. 2010;131:710-717
37. Paukku K, Backlund M, De Boer RA, Kalkkinen N, Kontula KK, Lehtonen JY. Regulation of AT1R expression through HuR by insulin. Nucleic Acids Res. 2012;40:5250-5261
38. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: Structure, regulation and function. Mol Cell Biochem. 2004;259:197-209
39. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol. 2003;30:860-866
40. Xu J, Carretero OA, Liao TD, et al. Local angiotensin II aggravates cardiac remodeling in hypertension. Am J Physiol Heart Circ Physiol. 2010;299:H1328-H1338
41. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK, Schoepp DD. Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol. 1988;146:85-95
42. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb. 1993;13:90-97
43. Liu H, Ledingham JM, Mullaney I, Laverty R. Endothelial function in mesenteric resistance arteries from the genetically hypertensive rat. Clin Exp Pharmacol Physiol. 2002;29:405-411
44. Bagi Z, Feher A, Cassuto J, et al. Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes-role for Rho-kinase activation. Br J Pharmacol. 2011;163:1059-1068
45. Takeda-Matsubara Y, Matsubara K, Ochi H, Ito M, Iwai M, Horiuchi M. Expression of endothelial angiotensin II receptor mRNA in pregnancy- induced hypertension. Am J Hypertens. 2003;16:993-999
46. Berdasco M, Esteller M. Hot topics in epigenetic mechanisms of aging: 2011. Aging Cell. 2012;11:181-186.